WINGROVE THERESA (VP of Regulatory Affairs) sold 36.4% of their position (12.03K shares) of IMMUNOGEN, INC. on the open market
Open‑market sale worth $352.4K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/6/2024ACC: 0001415889-24-002872
Officer· VP of Regulatory Affairs
Since Jan 2019
-12.03K
Net shares
Net seller
$352.4K
Total sold
1
Open market trades
0B · 1S
4
Total transactions
29.64K acquired · 41.67K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+29.64K
Price / share
—
Trade value
—
% of position
865.1%
2/2/2024
3.43K→33.07K
Common Stock
Direct
Shares
−12.03K
Price / share
$29.30
Trade value
$352.39K
% of position
36.4%
2/5/2024
33.07K→21.04K
Total
Net shares
+17.61K
Net value
-$352.39K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/2/2024 | M · Option Exercise | +29.64K | — | — | 865.1% | 3.43K | 33.07K |
| Common Stock Direct | 2/5/2024 | S · Sale | −12.03K | $29.30 | $352.39K | 36.4% | 33.07K | 21.04K |
| Total | +17.61K | -$352.39K | ||||||
Derivative Transactions2
Restricted Stock Unit
Direct
Converts to
Common Stock
21.84K shares
Shares
−21.84K
Strike price
0
Held after
32.76K
Exercisable
—
2/2/2024
Restricted Stock Unit
Direct
Converts to
Common Stock
7.80K shares
Shares
−7.80K
Strike price
0
Held after
15.60K
Exercisable
—
2/2/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock21.84K shares | 2/2/2024 | M · Option Exercise | −21.84K | 0 | — | 32.76K |
| Restricted Stock Unit Direct | Common Stock7.80K shares | 2/2/2024 | M · Option Exercise | −7.80K | 0 | — | 15.60K |